Evidence-based tuberculosis diagnosis

PLoS Medicine

Volumn 5, Issue 7, 2008, Pages 1043-1049

  Pai, Madhukar ^a   Ramsay, Andrew ^b   O'Brien, Richard ^c  

^a MCGILL UNIVERSITY   (Canada)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c FOUNDATION FOR INNOVATIVE NEW DIAGNOSTICS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICE; DIAGNOSTIC TEST; EVIDENCE BASED MEDICINE; HEALTH CARE POLICY; LABORATORY DIAGNOSIS; PRACTICE GUIDELINE; REVIEW; TUBERCULOSIS; ARTICLE; HEALTH CARE PLANNING; HUMAN; RESEARCH; TUBERCULIN TEST; WORLD HEALTH ORGANIZATION;

EVIDENCE-BASED MEDICINE; HEALTH PLANNING GUIDELINES; HUMANS; RESEARCH; TUBERCULIN TEST; TUBERCULOSIS; WORLD HEALTH ORGANIZATION;

EID: 48749102366     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0050156     Document Type: Review

References (62)

1. Stop TB Partnership, World Health Organization (2006) The global plan to stop TB 2006-2015. Available: http://www.stoptb. org/globalplan/. Accessed 16 June 2008.
2. Raviglione MC, Uplekar MW (2006) WHO's new Stop TB Strategy. Lancet 367: 952-955.
3. World Health Organization (2007) New technologies for tuberculosis control: A framework for their adoption, introduction and implementation. Available: http://whqlibdoc. who.int/publications/2007/9789241595520_ eng.pdf. Accessed 16 June 2008.
4. World Health Organization, Special Programme for Research and Training in Tropical Diseases (2006) Diagnostics for tuberculosis. Global demand and market potential. Available: http://www.who.int/tdr/ publications/publications/tbdi. htm. Accessed 16June 2008.
5. Oxman AD, Lavis JN, Fretheim A (2007) Use of evidence in WHO recommendations. Lancet 369: 1883-1889.
6. Hill S, Pang T (2007) Leading by example: A culture change at WHO. Lancet 369: 1842-1844.
7. World Health Organization (2008) Moving research findings into new WHO policies. Available: http://www.who.int/tb/dots/ laboratory/policy/en/index4. html. Accessed 16 June 2008.
8. Pai M, McCulloch M, Enanoria W, Colford JM Jr. (2004) Systematic reviews of diagnostic test evaluations: What's behind the scenes? ACP J Club 141: A11-A13.
9. Daley P, Thomas S, Pai M (2007) Nucleic acid amplification tests for the diagnosis of tuberculous lymphadenitis: A systematic review. Int J Tuberc Lung Dis 11: 1166-1176.
10. Dinnes J, Deeks J, Kunst H, Gibson A, Cummins E, et al. (2007) A systematic review of rapid diagnostic tests for the detection of tuberculosis infection. Health Technol Assess 11: 1-196.
11. Flares LL, Pai M, Colford JM Jr., Riley LW (2005) In-house nucleic acid amplification tests for the detection of Mycobacterium, tuberculosis in sputum specimens: meta-analysis and meta-regression. BMC Microbiol 5: 55.
12. Goto M, Noguchi Y, Koyama H, Hira K, Shimbo T, et al. (2003) Diagnostic value of adenosine deaminase in tuberculous pleural effusion: A meta-analysis. Ann Clin Biochem 40: 374-381.
13. Greco S, Girardi E, Masciangelo R, Capoccetta GB, Saltini C (2003) Adenosine deaminase and interferon gamma measurements for the diagnosis of tuberculous pleurisy: A meta-analysis. Int J Tuberc Lung Dis 7: 777-786.
14. Greco S, Girardi E, Navarra S, Saltini C (2006) The current evidence on diagnostic accuracy of commercial based nucleic acid amplification tests for the diagnosis of pulmonary tuberculosis. Thorax 61: 783-790.
15. Jiang J, Shi HZ, Liang QL (2007) Diagnostic value of interferon-g in tuberculous pleurisy: A meta-analysis. Chest 131: 1133-1141.
16. Kalantri S, Pai M, Pascopella L, Riley L, Reingold A (2005) Bacteriophage-based tests for the detection of Mycobacterium tuberculosis in clinical specimens: A systematic review and meta- analysis. BMC Infect Dis 5: 59.
17. Liang QL, Shi HZ, Wang K, Qin SM, Qin XJ (2008) Diagnostic accuracy of adenosine deaminase in tuberculous pleurisy: A meta-analysis. Respir Med 102: 744-754.
18. Ling DI, Flores LL, Riley LW, Pai M (2008) Commercial nucleic-acid amplification tests for diagnosis of pulmonary tuberculosis in respiratory specimens: Meta-analysis and meta-regression. PLoS ONE 3: el536. doi:10.137l/ journal.pone.0001536
19. Martin A, Portaels F, Palomino JC (2007) Colorimetric redox-indicator methods for the rapid detection of multidrug resistance in Mycobacterium tuberculosis: A systematic review and meta-analysis. J Antimicrob Chemother 59: 175-183.
20. Mase SR, Ramsay A, Ng V, Henry M, Hopewell PC, et al. (2007) Yield of serial sputum specimen examinations in the diagnosis of pulmonary tuberculosis: A systematic review. Int J Tuberc Lung Dis 11: 485-495.
21. Menzies D, Pai M, Comstock G (2007) Meta-analysis: New tests for the diagnosis of latent tuberculosis infection: Areas of uncertainty and recommendations for research. Ann Intern Med 146: 340-354.
22. Morgan M, Kalantri S, Flores L, Pai M (2005) A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: A systematic review and meta-analysis. BMC Infect Dis 5: 62.
23. Pai M, Flores LL, Hubbard A, Riley LW, ColfordJM Jr. (2004) Nucleic acid amplification tests in the diagnosis of tuberculous pleuritis: A systematic review and meta-analysis. BMC Infect Dis 4: 6.
24. Pai M, Flores LL, Pai N, Hubbard A, Riley LW, et al. (2003) Diagnostic accuracy of nucleic acid amplification tests for tuberculous meningitis: A systematic review and meta-analysis. Lancet Infect Dis 3: 633-643.
25. Pai M, Kalantri S, Pascopella L, Riley LW, Reingold AL (2005) Bacteriophage-based assays for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: A meta-analysis. J Infect 51: 175-187.
26. Pai M, Riley LW, ColfordJM Jr. (2004) Interferon-gamma assays in the immunodiagnosis of tuberculosis: A systematic review. Lancet Infect Dis 4: 761-776.
27. Riquelme A, Calvo M, Salech F, Valderrama S, Pattillo A, et al. (2006) Value of adenosine deaminase (ADA) in ascitic fluid for the diagnosis of tuberculous peritonitis: A meta-analysis. J Clin Gastroenterol 40: 705-710.
28. Samienttro OL, Weigle KA, Alexander J, Weber DJ, Miller WC (2003) Assessment by meta-analysis of PCR for diagnosis of smear-negative pulmonary tuberculosis. J Clin Microbiol 41: 3233-3240.
29. Steingart KR, Henry M, Laal S, Hopewell PC, Ramsay A, et al. (2007) A systematic review of commercial serological antibody detection tests for the diagnosis of extra-pulmonary tuberculosis. Thorax 62: 911-918.
30. Steingart KR, Henry M, Laal S, Hopewell PC, Ramsay A, et al. (2007) Commercial serological antibody detection tests for the diagnosis of pulmonary tuberculosis: A systematic review. PLoS Med 4: e202. doi:10.1371/journal. pmed.0040202
31. Steingart KR, Henry M, Ng V, Hopewell PC, Ramsay A, et al. (2006) Fluorescence versus conventional sputum smear microscopy for tuberculosis: A systematic review. Lancet Infect Dis 6: 570-581.
32. Steingart KR, Ng V, Henry M, Hopewell PC, Ramsay A, et al. (2006) Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: A systematic review. Lancet Infect Dis 6: 664-674.
33. Tuon FF, Litvoc MN, Lopes MI (2006) Adenosine deaminase and tuberculous pericarditis - A systematic review with meta-analysis. Acta Trop 99: 67-74.
34. Wang L, Turner MO, Elwood RK, Schulzer M, FitzGerald JM (2002) A meta-analysis of the effect of Bacille Calmette Guerin vaccination on tuberculin skin test measurements. Thorax 57: 804-809.
35. Farhat M, Greenaway C, Pai M, Menzies D (2006) False-positive tuberculin skin tests: What is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis 10: 1192-1204.
36. Martin A, Panaiotov S, Portaels F, Hoffner S, Palomino JC, et al. (2008) The nitrate reductase assay for the rapid detection of isoniazid and rifampicin resistance in Mycobacterium tuberculosis: A systematic review and meta-analysis. J An timicrob Chemother 62: 56-64.
37. Pai M, Zwerling A, Menzies D (2008) Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection - An update. Ann Intern Med 149: 177-184.
38. Ling DI, Zwerling A, Pai M (2008) GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: A meta-analysis. Eur Respir J. E-pub 9 July 2008. doi:10.1183/09031936.00061808
39. Andersen P, Doherty TM, Pai M, Weldingh K (2007) The prognosis of latent tuberculosis: Can disease be predicted? Trends Mol Med 13: 175-182.
40. Trajman A, Pai M, Dheda K, van zyl Smit R, Zwerling A, et al. (2008) Novel tests for diagnosing tuberculous pleural effusion: What works and what does not? Eur Respir J 31: 1098-1106.
41. World Health Organization (2007) The global MDR-TB and XDR-TB response plan 2007-2008. Available: http://whqlibdoc.who. int/hq/2007/WHO_HTM_TB_2007. 387_eng. pdf. Accessed 16June 2008.
42. Hopewell PC, Pai M, Maher D, Uplekar M, Raviglione MC (2006) International standards for tuberculosis care. Lancet Infect Dis 6: 710-725.
43. Getahun H, Harrington M, O'Brien R, Nunn P (2007) Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: Informing urgent policy changes. Lancet 369: 2042-2049.
44. World Health Organization (2007) Reduction of number of smears for the diagnosis of pulmonary TB. Available: http://www.who.int/ tb/dots/laboratory/ policy/en/index2.html. Accessed 16June 2008.
45. World Health Organization (2007) Definition of a new sputum smear-positive TB case. Available: http://www.who.int/tb/dots/ laboratory/policy/en/indexl. html. Accessed 16 June 2008.
46. Squire SB, Belaye AK, Kashoti A, Salaniponi FM, Mundy CJ, et al. (2005) 'Lost' smear-positive pulmonary tuberculosis cases: Where are they and why did we lose them? Int J Tuberc Lung Dis 9: 25-31.
47. World Health Organization (2007) The use of liquid medium for culture and DST. Available: http://www.who.int/tb/dots/laboratory/ policy/en/index3.html. Accessed 16June 2008.
48. Ridderhof JC, van Deun A, Kam KM, Narayanan PR, Aziz MA (2007) Roles of laboratories and laboratory systems in effective tuberculosis programmes. Bull World Health Organ 85: 354-359.
49. World Health Organization, Special Programme for Research and Training in Tropical Diseases (2006) Request for applications: Diagnostic trial sites: Improving the diagnosis of tuberculosis through optimization of sputum smear microscopy. Available: http://www.who.int/tdr/grants/ grants/trial_sites.htm. Accessed 16 June 2008.
50. Foundation for Innovative New Diagnostics (2008) Market launch of improved fluorescence microscope scheduled for later this year. Available: http://www. finddiagnostics.org/news/press/zeiss_mar08. pdf. Accessed 16June 2008.
51. Cunningham J (2005) Rapid serological-based TB test evaluation: Prelim analysis. Stop TB Working Group on New Diagnostics. Available: http://www.stoptb.org/wg/new_diagnostics/ assets/documents/jane_cunningham.pdf. Accessed 16June 2008.
52. Perkins MD, Cunningham J (2007) Facing the crisis: Improving the diagnosis of tuberculosis in the HIV era.J Infect Dis 196 (Suppl 1): S15-S27.
53. Canadian Tuberculosis Committee (2007) Interferon gamma release assays for latent tuberculosis infection. An Advisory Committee Statement (ACS). Can Commun Dis Rep 33: 1-18.
54. HPA Tuberculosis Programme Board (2007) Health Protection Agency Position Statement on the use of Interferon Gamma Release Assay (IGRA) tests for tuberculosis (TB): Draft for consultation. Available: http://www.hpa.org.uk/web/ HPAwebFile/ HPAweb_C/1204186168242. Accessed 16June 2008.
55. National Tuberculosis Advisory Committee Australia (2007) Position statement on interferon-gamma release immunoassays in the detection of latent tuberculosis infection, October 2007. Commun Dis Intell 31: 404-405.
56. Pai M, Dheda K, Cunningham J, Scano F, O'Brien R (2007) T-cell assays for the diagnosis of latent tuberculosis infection: Moving the research agenda forward. Lancet Infect Dis 7: 428-438.
57. Pai M, O'Brien R (2006) Tuberculosis diagnostics trials: Do they lack methodological rigor? Expert Rev Mol Diagn 6: 509-514.
58. Small PM, Perkins MD (2000) More rigour needed in trials of new diagnostic agents for tuberculosis. Lancet 356: 1048-1049.
59. Banoo S, Bell D, Bossuyt P, Herring A, Mabey D, et al. (2006) Evaluation of diagnostic tests for infectious diseases: General principles. Nat Rev Microbiol 4: S21-S31.
60. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, et al. (2003) Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative. Ann Intern Med 138: 40-44.
61. Schunemann HJ, Oxman AD, Brozek J, Glasziou P Jaeschke R, et al. (2008) Grading quality of evidence and strength of recommendations for diagnostic tests and sn-ategies. BMJ 336: 1106-1110.
62. Stop TB Partnership Working Group on New TB Diagnostics (2007) Revised strategic plan of the Stop TB Partnership's Working Group on New Diagnostics. Available: http://www.stoptb.org/wg/new_diagnostics/ assets/documents/ Draft%20NDWG%20 Strategic%20Plan%20for%20Cape%20 Town%20Meeting.pdf. Accessed 16 June 2008.